Empagliflozin, a SGLT, may alleviate side effects of type 2 diabetes & have positive effects on LV function- increase in SERCA function & improves myocardial insulin sensitivity and diastolic function in diabetic mice 🐁 Future use for humans? #bio
RT @ICAN_Institute: Empagliflozin improves left #ventricular #diastolic #dysfunction in a #genetic model of type 2 #diabetes https://t.co/H…
RT @ICAN_Institute: Empagliflozin improves left #ventricular #diastolic #dysfunction in a #genetic model of type 2 #diabetes https://t.co/H…
Empagliflozin improves left #ventricular #diastolic #dysfunction in a #genetic model of type 2 #diabetes https://t.co/HpUYIE1rL3 #calcium